Lex Rutten

Lex Rutten

Auto-generated profile, based on publicly available information

Lex Rutten

Independent Researcher, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Homeopathy
Verified
Journal Article
Closed access
ARA.L.B. Rutten
A.L.B. Rutten
CSC.F. Stolper
C.F. Stolper
There is a discrepancy between the outcome of a meta-analysis published in 1997 of 89 trials of homeopathy by Linde et al and an analysis of 110 trials by Shang et al published in 2005, these reached opposite conclusions. Important data were not mentioned in Shang et al's paper, but only provided subsequently. What was the outcome of Shang et al's predefined hypotheses? Were the homeopathic and conventional trials comparable? Was subgroup selection justified? The possible role of ineffective treatments. Was the conclusion about effect justified? Were essential data missing in the original article? Analysis of post-publication data. Re-extraction and analysis of 21 higher quality trials selected by Shang et al with sensitivity analysis for the influence of single indications. Analysis of comparability. Sensitivity analysis of influence of subjective choices, like quality of single indications and of cut-off values for 'larger samples'. The quality of trials of homeopathy was better than of conventional trials. Regarding smaller trials, homeopathy accounted for 14 out of 83 and conventional medicine 2 out of 78 good quality trials with n<100. There was selective inclusion of unpublished trials only for homeopathy. Quality was assessed differently from previous analyses. Selecting subgroups on sample size and quality caused incomplete matching of homeopathy and conventional trials. Cut-off values for larger trials differed between homeopathy and conventional medicine without plausible reason. Sensitivity analyses for the influence of heterogeneity and the cut-off value for 'larger higher quality studies' were missing. Homeopathy is not effective for muscle soreness after long distance running, OR=1.30 (95% CI 0.96-1.76). The subset of homeopathy trials on which the conclusion was based was heterogeneous, comprising 8 trials on 8 different indications, and was not matched on indication with those of conventional medicine. Essential data were missing in the original paper. Re-analysis of Shang's post-publication data did not support the conclusion that homeopathy is a placebo effect. The conclusion that homeopathy is and that conventional is not a placebo effect was not based on comparative analysis and not justified because of heterogeneity and lack of sensitivity analysis. If we confine ourselves to the predefined hypotheses and the part of the analysis that is indeed comparative, the conclusion should be that quality of homeopathic trials is better than of conventional trials, for all trials (p=0.03) as well as for smaller trials (p=0.003).

1 January 2009 in Homeopathy
Verified
Journal Article
Closed access
ARA.L.B. Rutten
A.L.B. Rutten
CSC.F. Stolper
C.F. Stolper
RLR.F.G. Lugten
R.F.G. Lugten
RBR.W.J.M. Barthels
R.W.J.M. Barthels
After prospective assessment of six homeopathic symptoms we validated some rubrics of the homeopathic repertory using Bayesian theory. In this paper we introduce statistical arguments for introducing or discarding entries from the repertory. 4094 patients entered the prospective study and 4072 prescriptions were evaluated. After translating typeface into Likelihood Ratios (LRs), Confidence Intervals and the probability of existing repertory entries compared to our findings were calculated. Our assessment yielded 121 relevant results to validate existing repertory entries. Five symptoms could be compared with Kent's original repertory; they have about the same prevalence (range 3.9-6.5%) in the whole population, but the size of the corresponding repertory rubrics varies from 3 to 103 entries. LR assessment reduced the larger rubrics and supplemented the smaller ones. Our results do not correspond with 56% of the existing repertory entries regarding five symptom-rubrics. This result cannot be generalised for the whole repertory.

27 April 2012 in Medicine, Health Care and Philosophy
Verified
Journal Article
Closed access
PDF file
LRLex Rutten
Lex Rutten
RMRobert T. Mathie
Robert T. Mathie
PFPeter Fisher
Peter Fisher
MGMaria Goossens
Maria Goossens
MWMichel van Wassenhoven
Michel van Wassenhoven

4 January 2021 in Homeopathy
Verified
Journal Article
Closed access
PDF file
LRLex Rutten
Lex Rutten
TSTom Smedley
Tom Smedley
GIGalen Ives
Galen Ives
PGPeter Gold
Peter Gold
BMBernardo Merizalde
Bernardo Merizalde
JEJosé E. Eizayaga
José E. Eizayaga
Background A novel pandemic disease offered the opportunity to create new, disease-specific, symptom rubrics for the homeopathic repertory. Objective The aim of this study was to discover the relationship between specific symptoms and specific medicines, especially of symptoms occurring frequently in this disease. Materials and Methods Worldwide collection of data in all possible formats by various parties was coordinated by the Liga Medicorum Homeopathica Internationalis. As the data came in, more symptoms were assessed prospectively. Frequent analysis and feedback by electronic newsletters were used to improve the quality of the data. Likelihood ratios (LRs) of symptoms were calculated. An algorithm for combining symptom LRs was programmed and published in the form of an app. The app was tested against 18 well-described successful cases from Hong Kong. Results LRs of common symptoms such as ‘Fatigue’ and ‘Headache’ provided better differentiation between medicines than did existing repertory entries, which are based only on the narrow presence or absence of symptoms. A mini-repertory for COVID-19 symptoms was published and supported by a web-based algorithm. With a choice of 20 common symptoms, this algorithm produced the same outcome as a full homeopathic analysis based upon a larger number of symptoms, including some that are traditionally considered more specific to particular medicines. Conclusion A repertory based on clinical data and LRs can differentiate between homeopathic medicines using a limited number of frequently occurring epidemic symptoms. A Bayesian computer algorithm to combine symptoms can complement a full homeopathic analysis of cases.

1 July 2004 in Homeopathy
Verified
Journal Article
Closed access
ARA.L.B Rutten
A.L.B Rutten
CSC.F. Stolper
C.F. Stolper
RLR.F.G. Lugten
R.F.G. Lugten
RBR.W.J.M. Barthels
R.W.J.M. Barthels
If the likelihood ratio (LR) method is introduced, the repertory will gradually change as more symptoms are assessed. It will also change the use of the repertory: the most important medicines of each symptom rubric can be identified and relied on, even in large rubrics. This is also a good opportunity to correct structural shortcomings of the repertory, for instance, entries should be based on systematic analysis of materia medica instead of casual observations.

1 July 2015 in Homeopathy
Verified
Journal Article
Closed access
LRLex (A.L.B.) Rutten
Lex (A.L.B.) Rutten
Collection of data concerning case histories is not yet common in homeopathy despite its great importance for this method. Computer program development progresses slowly and discussion about requirements is scarce. Two Dutch projects assessed Materia Medica of some homeopathic medicines and six homeopathic symptoms. Especially the second project relied heavily on data collection. In both projects much effort was spent on consensus between participating doctors. There was much variance between doctors despite our consensus efforts. Assessing causality seems the most important source of bias, there is also much variance in assessing symptoms. Data collection software should be developed step-by-step, guided by close monitoring and feedback of participating practitioners.